APR 29, 2021 7:30 AM PDT

We've Now Collected Over 1 Million Coronavirus Sequences

WRITTEN BY: Tara Fernandez

Over 1.2 million genome sequences collected from 172 countries have been uploaded to a data-sharing site over the course of the pandemic. This is a major milestone for epidemiologists and researchers looking to track how SARS-CoV-2 emerged and evolved as it swept the globe. 

Critically, this data also helps scientists keeping a close eye on variants on the move (some of which are more transmissible or cause more severe forms of COVID). Such data is important to keep tabs on to ascertain whether emerging variants are able to evade current diagnostics and therapeutics.

The sequences were uploaded to GISAID, a popular global science initiative established in 2006 that is a valuable open-access source of genomic data on influenza viruses and SARS-CoV-2. Most of the coronavirus genome sequences were from samples isolated in the United States, Europe, and Asia.

Mapping the spread of the virus hasn’t been smooth sailing for all data contributors. Scientists in West Africa, for example, did not have the bioinformatics training required to effectively use the analytical tools on the GISAID platform. To address these challenges, GISAID affiliates conducted workshops to educate scientists on how to navigate the sequence display and analytical functions.

Still, experts note gaps in the data uploaded onto GISAID. Countries such as El Salvador and Lebanon that are experiencing massive outbreaks have only contributed a small number of entries. Also, not everyone agrees with the site’s fine print, which stipulates that users must agree not to publish studies using sequences without acknowledging their contributors.

Nevertheless, experts are pleasantly surprised by the degree of participation. As Tulio de Oliveira, from the KwaZulu-Natal Research Innovation and Sequencing Platform in Durban, South Africa says, “This is the first time I’ve seen people sharing so much data before publication.”

 

Source: Nature, GISAID.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
FEB 23, 2021
Genetics & Genomics
New Insight Into Genetic Basis of IBD From African-American Patients
FEB 23, 2021
New Insight Into Genetic Basis of IBD From African-American Patients
The small variations in the genome that lead to differences in biology, including risk for diseases, can't be assumed to ...
MAR 18, 2021
Clinical & Molecular DX
"Hey Alexa, Are My Heart Rhythms Normal?"
MAR 18, 2021
"Hey Alexa, Are My Heart Rhythms Normal?"
Smart speakers—devices such as Amazon’s Echo and the Google Home—lend a helping hand around the house, ...
MAR 22, 2021
Clinical & Molecular DX
Good Dog! Man's Best Friend Sniffs Out Prostate Cancer.
MAR 22, 2021
Good Dog! Man's Best Friend Sniffs Out Prostate Cancer.
Trained dogs can spot aggressive prostate cancers by detecting trace amounts of chemical biomarkers in urine samples, sa ...
APR 05, 2021
Clinical & Molecular DX
COVID Variants Can't Hide From CRISPR Diagnostic
APR 05, 2021
COVID Variants Can't Hide From CRISPR Diagnostic
New variants of the coronaviruses have emerged over the course of the pandemic through the natural evolutionary process ...
APR 13, 2021
Clinical & Molecular DX
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
APR 13, 2021
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
German researchers have developed an innovative method for continuously tracking and monitoring biomarkers and drugs cir ...
APR 12, 2021
Microbiology
New Lyme Test Can ID The DIsease Early
APR 12, 2021
New Lyme Test Can ID The DIsease Early
Lyme disease is a disease that is caused by four main species of bacteria, including Borrelia burgdorferi, which ar ...
Loading Comments...